18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report
暂无分享,去创建一个
P. Delvenne | R. Hustinx | P. Meunier | N. Blétard | O. Detry | J. Delwaide | W. Liu
[1] J. V. Campos,et al. [Hepatocellular adenoma]. , 2020, AMB : revista da Associacao Medica Brasileira.
[2] Adarsh Vijay,et al. Hepatocellular adenoma: An update. , 2015, World journal of hepatology.
[3] W. Jarnagin,et al. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[4] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[5] S. Baba,et al. Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2). , 2014, Clinical imaging.
[6] R. Hustinx,et al. Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. , 2014, World journal of gastroenterology.
[7] S. Berlangieri,et al. FDG PET/CT in the liver: lesions mimicking malignancies , 2014, Abdominal Imaging.
[8] C. Chan,et al. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. , 2013, World journal of gastroenterology.
[9] A. Girma,et al. Problème diagnostique posé par une lésion hépatique hypermétabolique en TEP à la fluorocholine (18F) : à propos d’un cas , 2013 .
[10] O. Couturier,et al. Unusual uptake of 18FDG by a hepatic adenoma. , 2013, Clinical nuclear medicine.
[11] M. Gulluoglu,et al. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT. , 2012, Clinical nuclear medicine.
[12] A. McIntosh,et al. Loss of liver FA binding protein significantly alters hepatocyte plasma membrane microdomains[S] , 2012, Journal of Lipid Research.
[13] A. Dennison,et al. Uptake of 18FDG by a Hepatic Adenoma on Positron Emission Tomography , 2011, Case reports in hepatology.
[14] Soon-Young Song,et al. F-18 FDG uptake in focal fatty infiltration of liver mimicking hepatic malignancy on PET/CT images. , 2011, Clinical nuclear medicine.
[15] D. Jain,et al. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance , 2011, Pathology research international.
[16] C. Dejong,et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[17] D. Pezet,et al. Positive PET-CT scan in hepatocellular adenoma with concomitant benign liver tumors. , 2010, Gastroenterologie clinique et biologique.
[18] J. Zucman‐Rossi,et al. Subtype Classification of Hepatocellular Adenoma , 2010, Digestive Surgery.
[19] S. Fanti,et al. C-11 Acetate Does Not Enhance Usefulness of F-18 FDG PET/CT in Differentiating Between Focal Nodular Hyperplasia and Hepatic Adenoma , 2009, Clinical nuclear medicine.
[20] Feng Lu,et al. Primary hepatic tuberculoma appears similar to hepatic malignancy on F-18 FDG PET/CT. , 2009, Clinical nuclear medicine.
[21] L. Barthelmes,et al. Liver cell adenoma and liver cell adenomatosis. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[22] Hong-Mei Yu,et al. [Laparoscopic liver resection for benign liver tumors]. , 2004, Zhonghua yi xue za zhi.
[23] Jin Kim,et al. [Evaluation of various hepatic lesions with positron emission tomography]. , 2002, Taehan Kan Hakhoe chi = The Korean journal of hepatology.
[24] H. Alibazoglu,et al. 'False-positive' uptake of FDG in a hepatic adenoma. , 1997, Clinical nuclear medicine.
[25] O. Couturier,et al. Unusual Uptake of FDG by a Hepatic Adenoma , 2013 .
[26] M. Moriguchi,et al. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case , 2011, Surgery Today.
[27] R. Hustinx,et al. Hepatobiliary disease : primary and metastatic liver tumours , 2007 .